About 101,000 results
Open links in new tab
  1. Activated Partial Thromboplastin Time versus Antifactor Xa …

    The most common methods for monitoring UFH are the activated partial thromboplastin time (aPTT) and antifactor Xa heparin assay (anti-Xa HA), but both present challenges, and the …

  2. Activated Partial Thromboplastin Time versus Antifactor Xa …

    Cite this: Activated Partial Thromboplastin Time versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin by Continuous Intravenous Infusion - Medscape - Aug 01, 2011.

  3. aPTT and Anti-Xa Values in Patients Treated With UFH - Medscape

    Background: Both the activated partial thromboplastin time (aPTT) and anti-Xa assay can be used to monitor unfractionated heparin (UFH). Following implementation of an anti-Xa method for …

  4. Do Novel Anticoagulants Affect the PT/INR? - Medscape

    Jan 28, 2013 · More appropriate assays for dabigatran may be activated partial thromboplastin time (aPTT), diluted thrombin time (TT), or ecarin clotting time (ECT).

  5. Novel Tool May Predict Risk for ADRs in Pregnant Women

    The PREG-ADR tool may predict which pregnant women are at risk of developing adverse drug reactions.

  6. Diagnostic and Prognostic Markers in Sepsis - Page 3 - Medscape

    Clot Waveform Analysis In patients with sepsis, the optical transmission waveform obtained during measurement of the activated partial thromboplastin time is altered, giving a biphasic …

  7. Tarlatamab Approved for Advanced Small Cell Lung Cancer

    Jan 3, 2025 · Grade 3 or 4 laboratory abnormalities include decreased lymphocytes, haemoglobin, sodium, and potassium, as well as increased uric acid and activated partial …

  8. FDA Approves Imetelstat for Rare Low-Risk Blood Cancer

    Jun 7, 2024 · The US Food and Drug Administration (FDA) has approved imetelstat (Rytelo, Geron Corporation) for certain patients with relapsed or refractory low- to intermediate-risk …

  9. Disseminated Intravascular Coagulation in the Neonatal Period

    The most common tests used to evaluate coagulation and fibrinolysis are platelet count, prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen levels, and …

  10. Advances in Anticoagulation Management: The Role of Pharmacy

    Limitations in the use of the activated partial thromboplastin time (aPTT) test for heparin monitoring have been well recognized for a number of years. [1]